Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial
Trněný, Marek, Prof, Lamy, Thierry, Prof, Walewski, Jan, Prof, Belada, David, MD, Mayer, Jiri, MD, Radford, John, Prof, Jurczak, Wojciech, MD, Morschhauser, Franck, Prof, Alexeeva, Julia, MD, Rule, Simon, Prof, Afanasyev, Boris, Prof, Kaplanov, Kamil, MD, Thyss, Antoine, Prof, Kuzmin, Alexej, MD, Voloshin, Sergey, MD, Kuliczkowski, Kazimierz, Prof, Giza, Agnieszka, MD, Milpied, Noel, Prof, Stelitano, Caterina, MD, Marks, Reinhard, MD, Trümper, Lorenz, Prof, Biyukov, Tsvetan, MD, Patturajan, Meera, PhD, Bravo, Marie-Laure Casadebaig, MSc, Arcaini, Luca, Prof
Published in The lancet oncology (01.03.2016)
Published in The lancet oncology (01.03.2016)
Get full text
Journal Article